Insider Transactions in Q3 2023 at Syndax Pharmaceuticals Inc (SNDX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 09
2023
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
52,855
-74.77%
|
$951,390
$18.27 P/Share
|
|
Aug 09
2023
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
52,855
+42.78%
|
$422,840
$8.77 P/Share
|
|
Aug 02
2023
|
William Meury |
SELL
Open market or private sale
|
Direct |
83,000
-36.28%
|
$1,660,000
$20.46 P/Share
|
|
Aug 02
2023
|
William Meury |
BUY
Exercise of conversion of derivative security
|
Direct |
83,000
+26.55%
|
$664,000
$8.15 P/Share
|
|
Jul 31
2023
|
Keith A. Goldan Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
862
+19.81%
|
$15,516
$18.12 P/Share
|
|
Jul 10
2023
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct |
52,855
-74.77%
|
$1,057,100
$20.4 P/Share
|
|
Jul 10
2023
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct |
52,855
+42.78%
|
$422,840
$8.77 P/Share
|